BioStem Technologies

BioStem Technologies® is a pioneering leader in the development and manufacturing of innovative perinatal tissue-based allografts, specifically designed to enhance regenerative therapies. The clinic specializes in producing high-quality membrane allografts, including its flagship products: VENDAJE®, VENDAJE AC®, and VENDAJE® Optic. Utilizing the proprietary BioREtain® processing method, BioStem preserves the natural biological properties of perinatal tissue, ensuring that the structural integrity and matrix of fresh tissue are maintained. This commitment to quality is reflected in its accreditation by the American Association of Tissue Banks (AATB), as well as compliance with FDA regulations and Current Good Tissue Practices (cGMP). At BioStem Technologies, the mission is centered on improving patients' quality of life through scientific innovation and a stringent quality assurance system. By focusing on the unique properties of perinatal tissue, the clinic aims to provide advanced solutions for chronic wound care and other regenerative applications. Their expertise in harnessing the natural healing potential of amniotic tissue positions them at the forefront of wound care advancements. With an emphasis on cutting-edge research and development, BioStem Technologies is committed to driving forward the field of regenerative medicine, ultimately changing lives through their transformative allograft products.